Skip to main content

Advertisement

Fig. 4 | BMC Medicine

Fig. 4

From: Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

Fig. 4

Impact of neoadjuvant chemotherapy on healthy tissue (PP). PP with neoadjuvant chemotherapy-related samples (n = 8) were compared to PP samples with no neoadjuvant chemotherapy (n = 9). Metabolic network analysis according to ADEMA results. The red, green, and blue arrows, respectively, indicate the metabolites that are predicted to increase, decrease, or remain stable in the population who received neoadjuvant chemotherapy

Back to article page